SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced...
Hence then, the article about co diagnostics inc announces closing of 7 0 million registered direct offering of common stock priced at the market under nasdaq rules was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules )
Also on site :
- Quote of the Day: Shakespeare’s Powerful Advice for Living up to Your Potential—‘Be Not Afraid of Greatness…’
- Adidas’ ‘Really Comfortable’ Retro Sneakers Go With Everything, and They’re on Sale for Under $60 at Amazon
- Before He Was a Scene-Stealer on ‘The Office,’ Creed Bratton Played Guitar on This 1967 Summer of Love Anthem